Cyrus Biotechnology Inc.
We are a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. And we’re partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from discovery to the clinic. Cyrus is based in Seattle, WA and financed by leading US and Asian Biotech and Tech investors including Orbimed, Trinity Ventures, Springrock, Agent Capital, iSelect, Yard Ventures, WRF and Alexandria. We’ve worked with over 90 industry partners.
Company details
Find locations served, office locations
- Business Type:
- Software vendor
- Industry Type:
- Medical Research
- Market Focus:
- Nationally (across the country)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About us
Cyrus was founded out of the laboratory of David Baker at the University of Washington, based on the Baker Lab’s Rosetta protein design and modeling software. We created proprietary software using the latest methods in Rosetta and other bioinformatics tools to develop in-house and partnered programs. We also created an online GUI which brings the core suite of Rosetta algorithms to over 100 life science companies